Non-contact medication testing in bioen­er­getic testing methods

Non-contact medication testing in bioenergetic testing methods, particularly in kinesiology (RD, PE) and dental physioenergetics (ZPE), using the Rossaint Frequency Resonator (RFR)

Dr. A. Rossaint, Aachen.

(Hier und Jetzt, vol. 2, 4/2000, pp. 11–16)

In this article I would like to describe the situation of medication testing in bioenergetic regulation methods, particularly kinesiology, and here especially regulation diagnostics (RD, Klinghardt), physioenergetics (PE, V. Assche) and ZPE (Rossaint). A new product for non-contact resonance testing—the RFR—provides a welcome and unique aid for all these methods and has already been successfully presented at various universities in Italy and Austria.

I probably need say no more about kinesiology in GPW. ZPE (Rossaint), which developed primarily from physioenergetics (V. Assche), is of interest not only to holistic dentistry but can be used in every branch of medicine. (For further details on this and kinesiology in general, see the author's book: Ganzheitliche Zahnheilkunde. Hüthig-Verlag, 4th edition, 1997.)

Like most of the types of kinesiology known today (approximately 50!), it draws individual elements from many schools and combines them into a new, complex system.

The basis of ZPE is, on the one hand, physioenergetics (PE) with the arm reflex according to R. V. Assche; on the other, the classical AK muscle test according to Goodheart and the Omura test (BOT) are two further important pillars, particularly the latter's modification as acupuncture-point biophoton testing (ABT) according to Van Benschoten, who was able to attribute energy emissions at acupuncture points to biophotons. Elements of auriculomedicine (AM) (Nogier, Bahr) also play a role, particularly concerning foci, interference fields and heavy-metal burdens (Strittmatter, Bahr), as does Beardall's biocomputer model. Finally, explanatory models concerning the autonomic nervous system, the significance of the vagal ganglion (Williams) and parts of psychokinesiology (Klinghardt) have been incorporated from neural kinesiology (Williams, Klinghardt) and RD (Klinghardt).

EAV, like dental kinesiology, also makes a substantial contribution to ZPE, into which the author has incorporated intraoral massage (MIM) and many other subjects, such as the significance of particular acupuncture points, the odontogenic challenge, the consideration of acupuncture points and mudras as structural and functional holograms respectively, and a philosophy of life in the sense of Hermetic philosophy—and now non-contact medication testing.

Although it starts from the stomatognathic system, ZPE places the human being as a whole, with the content of their life and learning, at the centre of its considerations. Its conception of humanity sees the human being as a microcosm within the macrocosm, thus connecting not only with Paracelsus but also with Chinese acupuncture philosophy and the Indian Veda.

Every medical or dental intervention should follow these maxims, so that today's customary, purely symptomatic medicine and dentistry can become a medicine or dentistry of destiny. The seven Hermetic principles, particularly the law of content and form and the law of analogy, therefore play a substantial role in diagnosis and therapy.

Anyone engaged in bioenergetic methods, and thus working on the basis of information medicine, knows not only about the interconnectedness and diversity of the phenomena involved but is also more or less aware of the difficulties of the various explanatory models. After all, we are dealing with a relatively young discipline that has not yet exhausted its potential for development and explanation, and in which many surprises can still be expected, both in previously unknown diagnostic possibilities and in therapeutic successes. From the perspective of natural science, despite modern physical insights (quantum physics, quantum philosophy (Warnke)), we still lack adequate explanations—though this is due more to natural science's overly narrow, purely causal-analytical worldview. This does not detract from practicability and effectiveness; quite the contrary.

Behind everything, in any case, there should be a holistic view of the world and therefore of humanity, for whose understanding a “higher, divine perspective is indispensable” (Risi).

The author has been involved with bioenergetic regulation methods for approximately 30 years, initially with instrument-based methods (e.g. EAV), then increasingly with “hands-on” methods such as auriculomedicine and kinesiology.

Despite the diversity of methods—EAV, BFD, ENT, VRT, ET, Prognos, AM, radiesthesia, radionics and kinesiology, to name only the most important—they all share the use, through their respective techniques, of appropriate, suitable, so-called resonant remedies, test substances and medications for both diagnosis and therapy. (For more on the underlying philosophy of life in terms of analogy, see the author's book mentioned above.)

The phenomenon of medication testing is undisputed in empirical medicine and has its foundations in the anatomical and functional structures of the matrix (Pischinger's ground system), with its proteoglycans, structural glycoproteins and glucosamines. As a dissipative structure, it represents an original system for transmitting information and excitation, capable of rapid conformational change. As an interface between the material and spiritual worlds (matter-space and charge-space), it thus makes medication testing possible in the first place.

While the phenomenon of resonance diagnosis was already known to the Sumerians, Aztecs and Indians—the former already distinguished, among others, between water and oil physicians, who used subtle-energy methods to test medications and whether water was suitable for human consumption—medication testing was rediscovered in modern times, particularly for therapeutic purposes, by Voll and colleagues in the early 1950s.

All the “schools” have attempted to validate subjectively perceived results using objective criteria for the resonance phenomena involved, in order to gain recognition from natural science as well.

Attempts were already made in the 1970s to perform medication testing solely with specially constructed machines (Bergold, Euratom), but without success.

Even today it has not been possible to exclude the human component. The work presented in 1999 by the EAV Society (Heyer) confirms this, although, as a commendable advance, it succeeded for the first time in having a computer subsequently reproduce improvements in measured values previously achieved by a physician through medication testing.

Anyone practising electroacupuncture knows that occasionally medications have been found suitable—in other words, resonance has occurred—even though the cable connecting the patient to the medication honeycomb was no longer attached. Unbeknown to us, this was really the birth of non-contact medication testing, although at the time, in the 1970s, we found it rather embarrassing when it happened because we lacked explanatory models.

How is this phenomenon possible, and how does medication transfer actually work in that case?

At the time, the attempted explanation was that medications act through their electromagnetic field at distances of up to approximately 60 cm and resonate with the electromagnetic field of the person being examined, producing a change in the measured value or a different muscle tone when resonance occurs.

More recent investigations in acupuncture-point biophoton research (ABF) by Omura and Van Benschoten, however, showed that information transfer no longer occurred if aluminium foil approximately 0.3 mm thick was placed on the patient's forehead. Of all optical filters placed on the forehead, only an indigo filter, whose associated anatomical region is the forehead, could also interrupt it. It was therefore not electromagnetic but photoelectric in nature.

ABF also found that the signals required for medication testing lie in the infrared range between 780 and 1000 nm; the possibility that transmission operates through UV modulation of an infrared carrier wave is also being discussed (M. M. Van Benschoten / P. U. Eckhoff). This would explain why medication testing over acupuncture points can also be performed through clothing. It covers not only visible light but also the UV and IR ranges, and probably more besides, as experience with the RFR suggests and quantum philosophy shows.

Investigations into shielding the forehead with the above-mentioned indigo filters or aluminium foil, with the limbic system behind it that is chiefly responsible for the emotional processing of information, showed the following mechanism of information transmission: the patient's or subject's bioinformation travels via their brainwaves, is projected into the examiner's frontal cortex and generates resonance there. Through the interaction between the two people and the medications, this is then expressed in the practitioner as an unconsciously altered muscle tone or, in electrodiagnostics, a different contact pressure. (V. Benschoten)

Omura in particular demonstrated that the metal hand electrodes no longer needed to be placed in the hand but could instead be put in an acrylic-glass tube and directed towards the patient from a distance of 30 to 45 cm to obtain the same results. In this arrangement, information transfer can also be blocked by “closing” the opening of the tube with the indigo filter mentioned above: medication testing no longer works if the indigo filter is placed in front of the end of the tube directed at the patient.

How far does the agreement between electrodiagnostics and the kinesiological muscle test extend here?

Initially, following electroacupuncture, Omura and Van Benschoten retained the aluminium honeycomb, copper cable and brass/silver electrodes, but—as just indicated—an acrylic-glass tube was slipped over the hand electrode.

When measurements were taken using electrical devices, it soon became apparent that Voll's degeneration vessels could only be found with the devices' externally supplied current at voltages above 180 mV DC, whereas values below this suddenly revealed the organ systems for the peritoneum, sinuses, eyes, ears and skin at the degeneration vessels.

Later, Omura and Van Benschoten found that this displacement and distortion of the meridians was also caused by the hand electrodes themselves, whether they were brass or silver.

To obtain the same results in electroacupuncture and ABT, the potentised electrode substances at D30 had to be placed in the honeycomb; in VRT, DNA D30 also had to be added to compensate for the different DNA structures of the organ preparations and the patient. Finally, DNA D12 was needed to measure all information at the peripheral Jing-Well points.

In view of the above-mentioned changes in the meridian meanings of Voll's degeneration vessels and the fact that individual acupuncture points have different meanings in different medical schools—for example, organ degeneration vessel (Voll) 1: EAV, organ degeneration of the lower body; acupuncture-point biophoton testing, statoacoustic nerve; auriculomedicine (Bahr), vitamin C interference-field indicator point; or YinTang: EAV, limbic system; auriculomedicine, control point of the reticular formation (oscillation); kinesiology, RNA/pineal gland; esogetics, pineal gland/wisdom teeth; ZPE, gold—acupuncture points should be regarded as structural holograms (Rossaint). The answer to test questions depends on the system of meaning into which the practitioner has consciously connected and/or which test substance is used. The same applies to mudras, which should be regarded as functional holograms (Rossaint), since the same mudra can have different meanings, or one meaning can be captured by different mudras.

The RFR was constructed on the basis of findings from acupuncture-point biophoton research (Omura, V. Benschoten).

From kinesiology, especially PE, the author knew that medications placed locally on the skin are significant only for that location and its structures, whereas for the body as a whole a new whole-body somatotopy has to be created, using an open black ring filter as known from auriculomedicine

(Nogier, Bahr). This is placed on the skin during inhalation, causing the energy bodies to focus in the filter as through the eye of a needle and to create this whole-body somatotope. Any medications and substances placed inside the filter then allow statements to be made about effects on the whole body.

Consistently pursuing the above ideas, incorporating the finding that interaction between patient and medication via the physician takes place through photons or vortices, and following the basic idea of eliminating as many interfering metals as possible, the author gradually replaced the individual components of the classical test-set arrangements—brass/silver, copper cable/aluminium honeycomb—with acrylic glass. The aim was to see whether medication testing (resonance testing) using bioenergetic methods, particularly the kinesiological muscle test or AR and the bidigital O-ring test (BOT, Omura), would still work.

And indeed, it not only worked but worked even “better”: a booster effect occurred, particularly in diagnosis. Muscle testing became easier, required less force, responded more quickly and was therefore more precise, more reliable and more comfortable for the patient.

This is particularly true when comparing the results obtained by placing the test substances or medications directly against or on the body, or in the hand.

Following the above reasoning and considering the customary handling of medication testing—putting medications in the hand or on the body—one notices that the effect actually present only locally has been mentally “overridden” in favour of a whole-body effect. This again shows that resonance testing is more than a purely physical measurement and confirms from another perspective the importance of the human component and its consciousness. The “emptier” practitioners can make themselves while maintaining an alert consciousness or attentive awareness, the better medication testing works. In this way they consciously enter the “emptiness of space,” described in ancient traditions as “Akasha” and in quantum physics as charge-space (“vacuum ether,” spiritual space), which in turn corresponds to Sheldrake's “morphic field.”

Accordingly, no phenomenon or object to be researched or examined can be separated from the researcher or examiner (Warnke). This insight from quantum physics (quantum philosophy) is foreign to classical natural science, but it makes medication testing possible as a mental act of information transfer.

As often happens with new ideas because of Sheldrake's morphogenetic fields, so it happened here: after sending out brochures following completion of the acrylic-glass testing device and gaining some experience with it, the author learned from Mr Eckhoff (Bünde) that Van Benschoten was now also working exclusively with acrylic glass. However, he did not insert a fibre-optic cable between the parts, but placed the tube, without a hand electrode inside it, directly against the honeycomb and pointed it towards the patient.

With this arrangement, which also works well, the author did not find the booster effect mentioned above; it occurred only when the acrylic-glass hand electrode was additionally placed in the tube. The distance to the patient was also smaller when the tube without the hand electrode lay directly against the honeycomb. Moving it towards the patient with the acrylic-glass hand electrode inserted allows the distance at which a 100% effect is still present to be extended to 1 metre or more. This is especially true of the new version of the device, in which the hand electrode and tube are coupled to a cut-off corner of the honeycomb. This concentrates the energy emerging from the tube.

Depending on the arrangement of the testing area, or when travelling, the configuration just mentioned is as suitable as the one in which a glass-fibre/synthetic-fibre (PMMA) cable is inserted between the honeycomb and the tube containing the hand electrode.

The latter arrangement has the advantage that the honeycomb can be loaded somewhere other than where the tube is directed towards the patient, for example by an assistant. It is therefore particularly suitable when the patient is lying down, but in ZPE it is also used with seated patients, since testing there takes place almost exclusively while seated. It also allows particular organs and zones to be “targeted” without moving the entire RFR assembly.

Signals from substances, medications and so forth introduced into the space above and below the honeycomb—within its edges—can also be detected and used for diagnostic and therapeutic purposes.

The tube with its internal hand electrode, when connected to the cable and held over an area of skin, and the cable itself, when held directly over a skin location, also permit direct resonance testing (Omura) for organs, meridians and substances, such as heavy metals, medications and neurotransmitters. The latter, especially heavy metals, allow measurement of intracellular burdens, or, for medications, the concentration still present after a period of time (effective level).

For this purpose, either the patient holds the cable end at the relevant location to be examined by direct resonance—for example, GB14 for the brain in the case of heavy metals—or a surrogate person does the same while being tested and connected to the system at the other end of the honeycomb by a light-guide cable and a hand electrode.

“Scanning” with the tube, including the electrode, up to approximately 5 cm above the skin also permits identification of two identical substances over a larger area, which can then be precisely localised using the cable.

The substance being examined, or the histological organ or pathology preparation as a microscope section or slide, then only needs to be placed on the honeycomb. It no longer has to be held directly over the area being examined, as in Omura's method with the brass rod and the substance in the hand.

One possible explanation for the booster effect is a so-called “photon tunnel,” which may arise from the arrangement in the tube described above.

The photon tunnel was discovered only recently (G. Nimtz, Cologne). It means that, when information was transferred through several parallel acrylic-glass walls, the information—specific microwaves in the experiment—emerged from the final wall faster than mathematical calculations allowed; according to those calculations, initially no information at all should have emerged on the other side.

Whether it is photons at all that make resonance testing possible remains open. There may, and probably do, exist entirely different explanatory models. In particular, one should consider a vortex of energy in the sense of Schauberger's implosion, the opposite of explosion, or a completely different form of energy. After all, one must remember that only a very small spectrum of all radiation is used, and that the necessary human component brings entirely different dimensions into the test arrangement, especially in terms of the five-body model.

On the basis of the characteristics of the distinction known from quantum physics between matter-space—atomic nuclei, electrons, dependent on mass and the speed of light, vectorial, transverse waves, electromagnetic field—and charge-space—virtual energy-space, scalar field, independent of mass and the speed of light, longitudinal waves, “vacuum ether,” virtually instantaneous information storage and transmission—it may be assumed that the latter plays the main role. The vortex structures arising in these phenomena probably communicate with the scalar field through characteristic patterns.

Since human beings, as open systems, belong to both spaces, information exchange is also a mental act. In my opinion this explains why medication testing (resonance testing) works only through the human component mentioned above. If, however, one day it becomes possible to perform medication testing with computers alone, this would be a purely physical transmission of structures from matter-space and thus a purely symptomatic action. Although it could produce certain physical and physiological effects, it would have nothing to do with healing in the broader sense and would even exclude it. For healing remains connected with sanctification—becoming whole—which includes the “experience of the real” (Döbereiner), and therefore transcendence and metaphysics, in which the human being cannot be excluded.

In any case, a carrier wave (form wave) emerges both from the honeycomb itself and from the end of the tube directed towards the patient (Lecher antenna setting: 7.4) (Kunnen). The carried waves of the various medications inserted into the honeycomb are modulated onto it, thereby producing their specific, differentiated effect. This happens particularly intensely—fourfold—in the new version, in which the hand electrode and tube are docked at a cut-off corner of the honeycomb, creating an additional kind of pyramid effect.

The farther the tube is shifted towards the outer third of the hand electrode, the greater the distance that can be maintained between patient or subject and tube without loss of energy (100%): at half the approximately 11 cm hand electrode, the measurement distance (100%) is about 1.5 m; at the whole electrode it is almost 5 m (!). This applies especially to the new version described above, because of the pyramid shape and the crossing of the form waves, with energy concentrated in the large central bowl and the cis- and trans-central honeycomb holes.

Let us leave scientific explanatory models aside for the moment. What matters in practice is that the system works, offers many advantages and—as colleagues have now confirmed to me without exception—makes testing easier.

Another major advantage of the RFR is that it allows better self-testing when the tube is directed towards oneself.

By now, a number of users and I have accumulated considerable experience and continue to be amazed by the many further uses and applications of the resonance test set.

In practice it serves not only for ordinary resonance testing of allopathic or homeopathic medications; it can also be used for material testing and identifying allergens.

So-called energetic autonosodes (isopathic preparations) can also be produced. This application is particularly fascinating. An ampoule of seawater, a tube of alcohol or unmedicated globules is placed either in the acrylic-glass honeycomb or in front of the tube opening on the side facing the patient. It is left there throughout the testing process, from taking the case history to completed medication testing, including during a psychokinesiological session and treatment.

At the end, one determines, either mentally or using Bionikkorrelatur from Jahoda, Bensheim, which potency of the remedy the patient needs as additional support alongside the tested medications, and administers it in the identified potency for the corresponding period. Sometimes the isopathic “mother tincture” thus obtained is also used if the “processing mudra” identifies it as suitable when a parasympathetic muscle reaction—a weak muscle—occurs.

The potency level of the ampoules or globules placed in front of the tube is usually higher than that of those left in the honeycomb. If, for example, a D potency is found for the latter, the “tube isopathic preparation” has a C or LM potency, which the patient takes alongside the other tested medications. It has an astonishingly beneficial, intensifying effect that supports the rest of the therapy, particularly for psychological and emotional problems, including in Hellinger's sense.

Next, the Rossaint Frequency Resonator can be “connected” to existing testing devices and computers with virtual programmes as an additional medication honeycomb for substances or preparations not included in the programme, by inserting one's own customary or new medications and materials.

This also applies in conjunction with a Möbius loop that may be in use, for example in the Scasys system.

Furthermore, the newly developed acrylic-glass medication pickup allows a larger number of ampoules to be “gathered” in the usual way—equivalent to a Kuf row box—before the identified individual ampoules are inserted into the honeycomb. Here too, spatial detection of a resonant remedy extends approximately to the third box.

A honeycomb can also be loaded for a particular indication, such as heavy metals or similar, and first tested as a whole simply by placing it against the main honeycomb. If there is a positive response, the individual substances can then be identified. For a medication to be detected by the test at all, its distance from the device must not exceed approximately 1/2 cm. When docking additional honeycombs, this means they should rest directly against it or be attached using the connectors supplied. It also means that a substance “accidentally” lying closer than 1/2 cm is always included in the test—so beware.

In ZPE, the tube is generally directed towards the patient at shoulder height so that, in accordance with auriculomedicine, it reaches both central structures above the collarbone, with higher parasympathetic tone, and peripheral structures below the collarbone, with higher sympathetic tone (Strittmatter, Bahr, Nogier).

This also detects any inversion present, meaning a reversal of reflexes, which in ZPE, as in auriculomedicine, constitutes an absolute obstacle to diagnosis and treatment (anatomical structure: stellate ganglion with blockage of the first rib).

When choosing materials for fillings, crowns and so forth in holistic dentistry, the tube must therefore be directed only centrally or only peripherally, depending on the purpose: peripherally when testing new materials through the honeycomb, since peripheral application means adding information, by analogy with AM, whereas central application means removal. Central application is therefore particularly indicated when testing the tolerability of material already in the mouth. If, for example, gold is applied centrally and a muscle reaction (MR) or +AR is obtained, especially after a symptom has previously been stored in the biocomputer, the gold acts as a removal: one then knows that the stored symptom is being maintained by the gold.

In this way, after amalgam removal for example, central application can establish whether symptoms are still being maintained by “amalgam residues,” and appropriate remedies can be prescribed.

Conversely, if the MR (+AR) occurs immediately on peripheral application, one knows that the newly added material is incompatible. In all of this, it must be noted that information emerging from the end of the tube facing the patient acts at approximately 35 to 45 degrees on either side: the “dispersion angle” is relatively large. A 100% effect, however, is present only within an angle of approximately 10 degrees.

Conversely, this means that no information transfer is obtained when the tube lies crosswise to the patient.

In principle, the RFR has the advantage that medications, materials and test substances are not energetically “loaded” and “contaminated” with the patient's extraneous vibrations through direct contact.

It is known from Lecher antenna testing (Kunnen) that the metal hand electrode has to be changed each time during resonance testing because information from the previous patient's medications is still modulated onto it.

In conjunction with the ABT biophoton mudra for yin emission (V. Benschoten), both the indication for acupuncture-point treatment as such and the number of needles can be tested by first inserting a needle into the honeycomb like a medication. The ABT yin mudra, held over PC6, must then produce no reaction; otherwise acupuncture is not indicated at that time. The total number of needles up to the next positive reaction (+AR, MR, VAS) gives the number of needles that need to be inserted for the particular indication.

Another interesting application of the RFR, demonstrating that the testing process is highly complex and must not and cannot be reduced to its physical aspect alone, is the use of mudras and other symbols drawn on transparent film and likewise placed on the honeycomb.

They then register just like a test substance and can be handled in exactly the same way.

The same naturally applies to microscopic preparations and slides of organs or pathogens.

X-ray images can also be used in this way. Using direct resonance testing with appropriate substances, Omura was able to demonstrate scientifically (see references) that all structures, whether anatomical—for example, vessels—or pathological, such as osteitis or tumours, are imprinted by X-rays onto an X-ray image and can be detected using BOT, AR or muscle testing.

This makes it possible not only to perform “screening” through the X-ray image but also to use it to obtain detailed information about pathologies inaccessible to the eye, provided one has the identical substrate suspected as the pathological process. As is known from direct resonance testing, this applies both qualitatively and quantitatively.

In the Indian five-body model, as D. Klinghardt has incorporated it into RD, these latter applications belong to the third and fourth levels. They show that practitioners wishing to heal the whole person must not take a reductionist approach but must always take into account the entire “knowing field” (Ulsamer, Hellinger) of the patient and of the room or place where testing takes place, corresponding to Sheldrake's morphic fields.

For the honeycomb and tube themselves, this means that they may need shielding against interfering radiation and that the place where they stand must be neutral—for example, free of geopathogenic stimuli, as should be the case with all bioenergetic testing methods, or of objects emitting their own radiation. A white sheet of paper, for example, is therefore suitable as a base.

With the RFR, a new chapter has been opened in bioenergetic testing methods, particularly RD, PE, ZPE and ABT.

I would welcome further suggestions and experiences.